Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Microbot Medical Inc buy The Goldman Sachs Group, Inc.

Microbot Medical Inc
Start price
€1.17
24.01.24 / 50%
Target price
€5.51
24.01.25
Performance (%)
64.36%
End price
€1.92
25.01.25
Summary
This prediction ended on 25.01.25 with a price of €1.92. With a performance of 64.36% the BUY prediction by The_Goldman_Sachs_Gr was a big success. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Microbot Medical Inc -11.864% -11.864% -53.671%
iShares Core DAX® -1.586% 5.028% 6.332%
iShares Nasdaq 100 -4.148% -0.125% 25.735%
iShares Nikkei 225® -6.302% 0.528% 41.384%
iShares S&P 500 -3.225% 0.470% 20.449%

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Microbot Medical Inc diskutieren
Prediction Buy
Perf. (%) 64.36%
Target price 5.510
Change
Ends at 24.01.25

Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $7.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for STEM provided by MarketBeat

The Goldman Sachs Group, Inc. 
0
Report Share
24.01.24
In the thread Trading Microbot Medical Inc
Prediction Buy
Perf. (%) 64.36%
Target price 5.510
Change
Ends at 24.01.25

Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten

The Goldman Sachs Group, Inc. 
0
Report Share
25.01.25